Markers for diagnosing infections
AssigneeMeMed Diagnostics Ltd.
InventorsMichal ROSENBERG, Alon ANGEL, Oded SHAHAM, Roy NAVON, Einav SIMON, Eran EDEN, Eran REINER
Life of this patent
Estimating the term…
Abstract
A method of diagnosing an infectious disease, including determining the severity of the disease, in a subject comprising measuring an expression level of at least one protein selected from the group consisting of TSG-14, AGER, ANG-2 and ST2 in a sample of the subject; and diagnosing the disease based on said expression level. Kits for carrying out the diagnosis are also disclosed.
Claims31
A method of treating a subject having an infectious disease comprising:
- (a) measuring an expression level of at least one protein selected from the group consisting of Tumor necrosis factor-inducible gene 14 protein (TSG-14), Advanced glycosylation end product-specific receptor (AGER), Angiogpoietin-2 (ANG-2) and -Interleukin 1 receptor-like 1 (ST2) in a sample of the subject so as to diagnose the infectious disease based on said expression level;
- and
- (b) treating the subject according to the diagnosis of the infection.
3-5. (canceled)
8-9. (canceled)
13-17. (canceled)
(canceled)
26-28. (canceled)
(canceled)
(canceled)
A kit for diagnosing an infection comprising detection reagents which specifically at least two determinants selected from the group consisting of TSG-14, AGER, ANG-2 and ST2.
34-35. (canceled)
37-42. (canceled)
44-45. (canceled)
47-48. (canceled)
Dependencies are inferred from the claim text.